FGF2 and autoimmune polyendocrinopathy: Interleukin-13 (IL13), interleukin1 receptor antagonist (IL1RA), basic fibroblast growth factor (bFGF), epidermal growth factor (EGF), platelet-derived growth factor-AA (PDGF-AA), PDGF-BB, and vascular endothelial growth factor (VEGF) in LPPRP and IL-13, tumor necrosis factor receptor-1 (TNF-R1), monokine induced by interferon-γ (MIG), and granulocyte-macrophage colony-stimulating factor (GMCSF) in APS were significantly higher in fPRPs compared with utPRP.